xAnts

xAnts

en-AU

Paradigm raises $16m for phase III trial of knee osteoarthritis treatment

2024-12-09

news

Paradigm raises $16m for phase III trial of knee osteoarthritis treatment

Paradigm receives firm commitments to raise $16 million through placement to institutional and sophisticated investors The funds will primarily support global phase III trial of iPPS to treat knee ...Read more

Recommendations